Pharmaceuticals

Obeticholic Acid Global Forecast: Market to Scale Up to $1.84 Billion by 2030 at 12.7% CAGR

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the obeticholic acid market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Obeticholic Acid Market by the end of 2030?

The obeticholic acid market has experienced substantial growth in recent years. Its value is projected to increase from $1.01 billion in 2025 to $1.14 billion in 2026, at a compound annual growth rate (CAGR) of 12.9%. This historical expansion can be attributed to several factors, including clinical approval for primary biliary cholangitis treatment, a rise in liver disease diagnoses, the broadening of hepatology clinics, enhanced awareness of bile acid regulation therapies, and the development of specialty liver drugs.

The obeticholic acid market is anticipated to undergo significant expansion over the next few years. It is projected to reach $1.84 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.7%. This expansion throughout the forecast period stems from various factors, including an escalating NASH patient population, the broadening of liver disease drug pipelines, better adoption of diagnostic screening, increased investment in hepatology research, and the global spread of oral liver therapies. Prominent trends observed during this period involve the rising incidence of chronic liver diseases, greater uptake of FXR agonist treatments, an increasing focus on disease-modifying liver medications, the expansion of nonalcoholic steatohepatitis research, and the growing utilization of oral hepatology treatments.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22079&type=smp

What Drivers Are Shaping Future Opportunities In The Obeticholic Acid Market?

The expanding occurrence of liver ailments is anticipated to boost the growth of the obeticholic acid market. These conditions impair the liver’s normal functioning. This increase in liver disease cases stems from excessive alcohol intake, which damages liver cells and compromises the organ’s function, potentially leading to inflammation, cirrhosis, and ultimately liver failure. Obeticholic acid assists patients with liver disease through the activation of the farnesoid X receptor (FXR), a mechanism that mitigates bile acid buildup, lessens liver inflammation, and retards the progression of fibrosis, thereby enhancing liver function. As an illustration, the Office for Health Improvement and Disparities, a UK government department, reported in December 2024 that premature deaths from alcoholic liver disease saw a 3.6% rise in 2023, totaling 5,984 fatalities, an increase from 5,776 in 2022. Consequently, the increasing prevalence of liver conditions is fueling the expansion of the obeticholic acid market.

Which Segments Are Gaining Traction In The Obeticholic Acid Market?

The obeticholic acid market covered in this report is segmented –

1) By Product Type: Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications

Subsegments:

1) By Immediate-Release Tablets: Standard Oral Tablets, Low-Dose Strength Tablets

2) By Modified-Release Tablets: Controlled Exposure Tablets, Once-Daily Optimized Release Tablets

3) By Film-Coated Tablets: Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets

Which Competitive Trends Are Impacting The Structure Of The Obeticholic Acid Market?

Leading firms within the obeticholic acid market are engaged in the creation of novel products, including farnesoid X receptor (FXR) agonists, aimed at advancing liver disease therapy and achieving better patient results. An FXR agonist functions as a compound that stimulates the FXR, which is a nuclear receptor crucial for governing bile acid metabolism, inflammation, and fibrosis within the liver. These farnesoid X receptor (FXR) agonists contribute to enhanced liver function and find application in addressing conditions like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). As an illustration, in February 2024, Intercept Pharmaceuticals Inc., a biopharmaceutical firm based in the US, disclosed the U.S. Food and Drug Administration (FDA)’s acceptance of its supplemental New Drug Application (sNDA) for Ocaliva, intended for the treatment of patients with primary biliary cholangitis (PBC). This acceptance by the FDA of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) represents significant regulatory advancement in confirming its clinical efficacy for PBC treatment.

Who Are The Primary Competitors In The Global Obeticholic Acid Market?

Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/obeticholic-acid-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Obeticholic Acid Market?

North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Obeticholic Acid Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22079&type=smp

Browse Through More Reports Similar to the Global Obeticholic Acid Market 2026, By The Business Research Company

Adipic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/adipic-acid-global-market-report

Polyglycolic Acid Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyglycolic-acid-global-market-report

Fatty Acids Market Report 2026

https://www.thebusinessresearchcompany.com/report/fatty-acids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795